Universal Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 4, 2026, reporting second-quarter and six-month financial results for its fiscal year.
Key Highlights
- Quarterly revenue declined: Sales and other operating revenues were $621,845 thousand for the three months ended September 30, 2026, compared with $754,177 thousand in the same period of the prior year, according to the filing.
- Net income attributable to Universal Corporation: $12,582 thousand for the second quarter, down from $34,169 thousand in the year-ago quarter, as reported.
- Diluted earnings per share: $0.50 for the three months ended September 30, 2026, versus $1.36 in the same prior-year period.
- Six-month net income attributable to Universal Corporation: $7,566 thousand for the six months ended September 30, 2026, compared with $42,666 thousand for the six months ended September 30, 2025.
- Dividends declared: $0.83 per common share for the quarter, up from $0.82 in the prior-year quarter.
- Shares outstanding: As of November 2, 2026, 24,927,007 shares of common stock were outstanding, the filing stated.
- Restructuring income: The company recorded restructuring and impairment income of $2,708 thousand in the second quarter of fiscal 2027, compared with no such item in the prior-year quarter.
Universal Corporation's Second-Quarter Results: Revenue and Earnings Decline Year Over Year
Universal Corporation (NYSE:UVV), a Virginia-incorporated leaf tobacco and ingredients company, reported that sales and other operating revenues for the three months ended September 30, 2026 totaled $621,845 thousand, a decrease from $754,177 thousand in the corresponding quarter of the prior fiscal year. For the six-month period, revenues were $1,145,624 thousand, down from $1,347,939 thousand, according to the filing. Cost of goods sold for the second quarter was $514,320 thousand, compared with $614,347 thousand in the prior-year quarter.
Operating income for the three months ended September 30, 2026 was $42,645 thousand, against $67,649 thousand in the same prior-year period. The filing reported a restructuring and impairment income item of $2,708 thousand in the current quarter. For the six-month period, operating income was $44,941 thousand, down from $101,462 thousand. Interest expense was $18,389 thousand for the quarter and $34,896 thousand for the six-month period, the filing disclosed.
On the balance sheet, total assets as of September 30, 2026 were $3,030,461 thousand, compared with $3,070,439 thousand at September 30, 2025 and $2,766,767 thousand at March 31, 2026. Notes payable and overdrafts rose to $579,287 thousand from $287,564 thousand at March 31, 2026, reflecting seasonal borrowing patterns typical of tobacco operations. Net cash used by operating activities for the six months ended September 30, 2026 was $213,782 thousand. The company also repurchased $5,000 thousand of common stock and paid $41,116 thousand in common stock dividends during the six-month period, per the filing.
What Was Disclosed
Universal Corporation's 10-Q for the quarter ended September 30, 2026 disclosed consolidated income statements, balance sheets, and cash flow statements on an unaudited basis, covering both the three-month and six-month periods, along with share count and per-share data.



Please wait processing your request...